The Scientist - USA (2020-01 & 2020-02)

ONDEMAND

CAR T Cell Therapy:

Overcoming Toxicities

WEBINAR SPONSORED BY

Following the success of the fi rst checkpoint inhibitors for treating cancer, many researchers are now turning their attention to chimeric antigen receptor (CAR)

T cell therapy. This novel treatment makes use of a cancer patient’s own T cells, which are removed and modifi ed so that they can better recognize and attack

cancer cells. These modifi ed cells are then infused back into the patient’s body. While this approach has shown some success for certain cancers, severe toxicities

have limited its widespread application. Researchers are attempting diff erent methods to overcome these toxic eff ects, including using gene-editing tools such as

CRISPR to modify CAR T cell protein production and employing antibody therapy to potentially block toxicity-inducing proteins. Will CAR T cell therapy emerge

as a game changer for cancer treatment? Or are the hurdles too high? Join The Scientist for an educational webinar, sponsored by Enzo, Nanostring, Sartorius, and

IsoPlexis, as we explore CAR T cell therapy research and gain insight into the next steps.

DAVID T. TEACHEY,MD

Associate Professor of Pediatrics

Children’s Hospital of Philadelphia

Department of Pediatrics

Perelman School of Medicine at the

University of Pennsylvania

ORIGINALLY AIRED

MONDAY, DECEMBER 2, 2019

WATC H NOW!

http://www.the-scientist.com/car-t-toxicities

R AWA N FARAMAND,MD

Assistant Member, Blood and Marrow

Transplant & Cellular Immunotherapy

H. Lee Moffi tt Cancer Center and

Research Institute

TOPICS COVERED:

• Diagnosing and managing CAR T cell therapy-related
  toxicities


• Identifying early predictive toxicity markers in patients
  treated with CAR T cell therapy

The search for solutions to the antibiotic resistance problem is moving beyond traditional antibiotic drugs, leading researchers to some unexpected

places. The Scientist is bringing together a panel of experts in the fi eld of antibiotic development to present their research on novel solutions for

overcoming superbugs that have developed resistance to traditional antimicrobials.

STEVE DIGGLE, PhD

Associate Professor

Center for Microbial Dynamics & Infection

School of Biological Sciences

Georgia Institute of Technology

BARNEY BISHOP, PhD

Associate Professor

Department of Chemistry and Biochemistry

George Mason University

LORI BURROWS, PhD

Professor

Biochemistry and Biomedical Sciences

Associate Director Michael G. DeGroote Institute

for Infectious Disease Research

McMaster University

THURSDAY, JANUARY 9, 2020

2:30 - 4:00 PM EST

REGISTER NOW!

http://www.the-scientist.com/

ancient-recipes-komodo-dragons

The webinar video will also be available at this link.

TOPICS TO BE COVERED:

• AncientBiotics: Medieval medicine and modern
  applications


• The identification and development of novel
  antimicrobial peptides from Komodo dragons


• Coopting the enemy–using biofilms to find
  antibiotics

From Ancient Recipes to the Blood of Komodo

Dragons: The Quest for a Solution to the Current

Onslaught of Superbugs

COMINGSOON